HDAC inhibitors (HDACis) have proved to be effective anticancer agents, owing to the potential capacity to inhibit cancer cell invasion, sensitize the cancer cells to chemotherapy, induce apoptosis, and boost immunogenicity [13]. Here, HDAC9 is linked to cancer.